Ivacaftor
Número de CAS
873054-44-5
Fórmula Molecular
C24H28N2O3
Peso Molecular
392.49
Pureza
98%
Punto de fusión
212-215°C
Solubilidad
DMSO (Slightly), Ethyl Acetate (Slightly), Methanol (Slightly)
Apariencia
White to Light Brown solid
Condiciones de almacenamiento
Refrigerator
Indicación
Cystic fibrosis
Descripción del Producto

In January 2012, the US FDA approved ivacaftor for the treatment of cystic fibrosis (CF) in patients who have the G551D mutation of the CF transmembrane regulator (CFTR) and are at least 6 years old.